These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


168 related items for PubMed ID: 26691741

  • 1. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms.
    van Vliet EA, Otte WM, Wadman WJ, Aronica E, Kooij G, de Vries HE, Dijkhuizen RM, Gorter JA.
    Epilepsia; 2016 Jan; 57(1):70-8. PubMed ID: 26691741
    [Abstract] [Full Text] [Related]

  • 2. Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging.
    van Vliet EA, Otte WM, Wadman WJ, Aronica E, Kooij G, de Vries HE, Dijkhuizen RM, Gorter JA.
    Epilepsia; 2016 Jan; 57(1):59-69. PubMed ID: 26691904
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.
    van Vliet EA, Forte G, Holtman L, den Burger JC, Sinjewel A, de Vries HE, Aronica E, Gorter JA.
    Epilepsia; 2012 Jul; 53(7):1254-63. PubMed ID: 22612226
    [Abstract] [Full Text] [Related]

  • 4. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study.
    van Vliet EA, Otte WM, Gorter JA, Dijkhuizen RM, Wadman WJ.
    Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rapamycin reveals an mTOR-independent repression of Kv1.1 expression during epileptogenesis.
    Sosanya NM, Brager DH, Wolfe S, Niere F, Raab-Graham KF.
    Neurobiol Dis; 2015 Jan; 73():96-105. PubMed ID: 25270294
    [Abstract] [Full Text] [Related]

  • 9. Spatio-temporally restricted blood-brain barrier disruption after intra-amygdala kainic acid-induced status epilepticus in mice.
    Michalak Z, Sano T, Engel T, Miller-Delaney SF, Lerner-Natoli M, Henshall DC.
    Epilepsy Res; 2013 Feb; 103(2-3):167-79. PubMed ID: 23182415
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy.
    van Vliet EA, da Costa Araújo S, Redeker S, van Schaik R, Aronica E, Gorter JA.
    Brain; 2007 Feb; 130(Pt 2):521-34. PubMed ID: 17124188
    [Abstract] [Full Text] [Related]

  • 12. Periodic acid-Schiff (PAS)-positive deposits in brain following kainic acid-induced seizures: relationships to fos induction, neuronal necrosis, reactive gliosis, and blood-brain barrier breakdown.
    Bennett SA, Stevenson B, Staines WA, Roberts DC.
    Acta Neuropathol; 1995 Feb; 89(2):126-38. PubMed ID: 7732785
    [Abstract] [Full Text] [Related]

  • 13. Cytidine 5'-diphosphocholine (CDP-choline) adversely effects on pilocarpine seizure-induced hippocampal neuronal death.
    Kim JH, Lee DW, Choi BY, Sohn M, Lee SH, Choi HC, Song HK, Suh SW.
    Brain Res; 2015 Jan 21; 1595():156-65. PubMed ID: 25446447
    [Abstract] [Full Text] [Related]

  • 14. Administration of simvastatin after kainic acid-induced status epilepticus restrains chronic temporal lobe epilepsy.
    Xie C, Sun J, Qiao W, Lu D, Wei L, Na M, Song Y, Hou X, Lin Z.
    PLoS One; 2011 Jan 21; 6(9):e24966. PubMed ID: 21949812
    [Abstract] [Full Text] [Related]

  • 15. Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis.
    Gorter JA, van Vliet EA, Aronica E.
    Epilepsy Behav; 2015 Aug 21; 49():13-6. PubMed ID: 25958228
    [Abstract] [Full Text] [Related]

  • 16. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.
    Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, Picot MC, Baldy-Moulinier M, Bockaert J, Crespel A, Lerner-Natoli M.
    Brain; 2007 Jul 21; 130(Pt 7):1942-56. PubMed ID: 17533168
    [Abstract] [Full Text] [Related]

  • 17. Levetiracetam treatment influences blood-brain barrier failure associated with angiogenesis and inflammatory responses in the acute phase of epileptogenesis in post-status epilepticus mice.
    Itoh K, Ishihara Y, Komori R, Nochi H, Taniguchi R, Chiba Y, Ueno M, Takata-Tsuji F, Dohgu S, Kataoka Y.
    Brain Res; 2016 Dec 01; 1652():1-13. PubMed ID: 27693413
    [Abstract] [Full Text] [Related]

  • 18. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.
    Drion CM, van Scheppingen J, Arena A, Geijtenbeek KW, Kooijman L, van Vliet EA, Aronica E, Gorter JA.
    J Neuroinflammation; 2018 Jul 23; 15(1):212. PubMed ID: 30037344
    [Abstract] [Full Text] [Related]

  • 19. Temporal profile of clinical signs and histopathologic changes in an F-344 rat model of kainic acid-induced mesial temporal lobe epilepsy.
    Sharma AK, Jordan WH, Reams RY, Hall DG, Snyder PW.
    Toxicol Pathol; 2008 Dec 23; 36(7):932-43. PubMed ID: 19126789
    [Abstract] [Full Text] [Related]

  • 20. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling.
    Haas KZ, Sperber EF, Opanashuk LA, Stanton PK, Moshé SL.
    Hippocampus; 2001 Dec 23; 11(6):615-25. PubMed ID: 11811655
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.